Anti-Mutant p53 antibody [Y5] (ab32049)

Publishing research using ab32049? Please let us know so that we can cite the reference in this datasheet.

ab32049 has been referenced in 18 publications.

  • Wang H  et al. Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance. Nat Commun 9:562 (2018). Flow Cyt . PubMed: 29422620
  • Waldherr M  et al. Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals? Arch Toxicol 92:921-934 (2018). PubMed: 29218508
  • Xie P  et al. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target. Cell Death Dis 8:e2834 (2017). WB . PubMed: 28569775
  • Chen YC  et al. Laser-emission imaging of nuclear biomarkers for high-contrast cancer screening and immunodiagnosis. Nat Biomed Eng 1:724-735 (2017). IHC ; Human . PubMed: 29204310
  • Tian C  et al. ABCG1 as a potential oncogene in lung cancer. Exp Ther Med 13:3189-3194 (2017). PubMed: 28588672
  • Lu Y  et al. Methylation and expression of RECK, P53 and RUNX genes in patients with esophageal cancer. Oncol Lett 14:5293-5298 (2017). WB ; Human . PubMed: 29113164
  • Huang CY  et al. Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer. Oncol Lett 14:3623-3627 (2017). PubMed: 28927122
  • Greenaway JB  et al. Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer. Oncotarget 7:47343-47365 (2016). WB, IF . PubMed: 27329838
  • Xiang JF  et al. Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9?=?1,000?U/mL. Sci Rep 6:25115 (2016). PubMed: 27174632
  • Lee HJ  et al. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma. BMC Oral Health 15:153 (2015). PubMed: 26626427
  • Xu Z  et al. Quantitative Proteomics Reveals That the Inhibition of Na(+)/K(+)-ATPase Activity Affects S-Phase Progression Leading to a Chromosome Segregation Disorder by Attenuating the Aurora A Function in Hepatocellular Carcinoma Cells. J Proteome Res 14:4594-602 (2015). PubMed: 26491887
  • Shi S  et al. Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer. Cancer Lett 360:227-33 (2015). IHC ; Human . PubMed: 25687883
  • Itou J  et al. An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer. Biochim Biophys Acta 1853:27-40 (2015). WB ; Human . PubMed: 25305574
  • Li Y  et al. Expression of p53, p21(CIP1/WAF1) and eIF4E in the adjacent tissues of oral squamous cell carcinoma: establishing the molecular boundary and a cancer progression model. Int J Oral Sci 7:161-8 (2015). IHC . PubMed: 25835715
  • Leiker AJ  et al. Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384. Clin Cancer Res 21:2792-801 (2015). PubMed: 25724523
  • Zandi R  et al. PRIMA-1Met/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53. Clin Cancer Res 17:2830-41 (2011). PubMed: 21415220
  • Nipic D  et al. Preapoptotic cell stress response of primary hepatocytes. Hepatology 51:2140-51 (2010). ICC/IF ; Rat . PubMed: 20513000
  • Goel VK  et al. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice. Oncogene 28:2289-98 (2009). IHC-P ; Mouse . PubMed: 19398955


Sign up